MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 12 filers reported holding MONOPAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $7,000 | -22.2% | 5,000 | +21.5% | 0.00% | – |
Q2 2022 | $9,000 | -10.0% | 4,116 | 0.0% | 0.00% | – |
Q1 2022 | $10,000 | -23.1% | 4,116 | 0.0% | 0.00% | – |
Q4 2021 | $13,000 | -35.0% | 4,116 | 0.0% | 0.00% | – |
Q3 2021 | $20,000 | -33.3% | 4,116 | -19.8% | 0.00% | – |
Q2 2021 | $30,000 | -47.4% | 5,130 | -43.8% | 0.00% | – |
Q1 2021 | $57,000 | – | 9,130 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
American Portfolios Advisors | 700 | $1,610 | 0.00% |
ROYAL BANK OF CANADA | 4,116 | $9,000 | 0.00% |
VANGUARD GROUP INC | 99,879 | $230,000 | 0.00% |
UBS Group AG | 19,561 | $45,000 | 0.00% |
IFP Advisors, Inc | 500 | $13,000 | 0.00% |
FMR LLC | 10 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 29 | $0 | 0.00% |
NORTHERN TRUST CORP | 35,203 | $81,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 39,171 | $85,000 | 0.00% |